ArticlebioRxiv : the preprint server for biology2026
Artificial intelligence aided design of peptides with custom secondary structure motifs and reduced amino acid alphabets.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Proteins are highly diverse functional polymers where the specific sequence of amino acids, selected from a standard genetically-encoded alphabet of twenty (C20), determines the structure and ultimately the function of the resulting folded protein. This standard alphabet has been identified to be non-randomly distributed in physicochemical properties crucial to both structure-formation and function, often referred to as coverage theory. While machine learning models have drastically improved protein structure prediction, success of protein design models lags structure prediction, particularly for custom secondary structure motifs and amino acid alphabets. Here we therefore bridge contemporary biological theory with recent advancements in artificial intelligence (AI) to develop and evaluate a generative AI protein design model, trained on hundreds of thousands of proteins within the RSCB PDB, for custom secondary structure motifs using reduced amino acid alphabets (RAAs). Results indicate an overall success in designing novel proteins with desired secondary structure motifs for a broad range of amino acid alphabets and complexity of designs. Interestingly, this tool often captures the full three-dimensional tertiary structure of a target protein despite training only on physicochemical sequence space and secondary structure information. The development of this model advances research across multiple disciplines, from general scientific AI architecture development to protein design for biotechnology, astrobiology, and early-Earth evolutionary biology.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.